Seres Therapeutics Inc

Biotech Stocks Healthcare Stocks

$13.96

+0.56 (+4.18%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 6 67%

Hold 3 33%

Sell 0 0%

Price Target

Analyst Price Target +84.3% upside

Low Target $18.91

Average Target $25.73

High Target $33.51

Current Price $13.96

Current
$13.96

Target
$25.73

$18.91 $25.73 avg $33.51

Scenario Analysis

Bear Case

$18.91

35.5%

Low target

Base Case

$25.73

+84.3%

Avg target

Bull Case

$33.51

+140.0%

High target

Risk/Reward

3.9x

Highly favorable

Price in Context

52-Week High

$21.52

-35.1% from high

52-Week Low

$15.95

+-12.5% from low

Target vs 52W High

$25.73

+19.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%